{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:40:06Z","timestamp":1749656406896,"version":"3.41.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.htct.2025.103759","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T11:40:06Z","timestamp":1746618006000},"page":"103759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the genetic profile of cytochrome P450 and glutathione S-transferases of patients diagnosed with acute myeloid leukemia"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5412-3737","authenticated-orcid":false,"given":"Gilmar de Andrade","family":"Fran\u00e7a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Nardinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4740-0867","authenticated-orcid":false,"given":"Ricardo Rodrigues","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3531-5428","authenticated-orcid":false,"given":"Thiago","family":"Pagliarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ot\u00e1vio C\u00e9sar Carvalho","family":"Guimar\u00e3es Baiocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9707-0579","authenticated-orcid":false,"given":"Elvira Deolinda Rodrigues Pereira","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wellington Fernandes da Silva","family":"Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Magalh\u00e3es Rego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4751-1428","authenticated-orcid":false,"given":"Israel","family":"Bendit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2025.103759_bib0001","unstructured":"Genome.Gov. Pharmacogenomics [Internet]. 2019 [cited April 16, 2024]. Available from: https:\/\/www.genome.gov\/genetics-glossary\/Pharmacogenomics."},{"key":"10.1016\/j.htct.2025.103759_bib0002","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.mayocp.2017.09.001","article-title":"Pharmacogenomics: precision medicine and drug response","volume":"92","author":"Weinshilboum","year":"2017","journal-title":"Mayo Clin Proc"},{"article-title":"Brazil. Instituto Nacional do C\u00e2ncer","year":"2021","series-title":"Estimativas 2020","key":"10.1016\/j.htct.2025.103759_bib0003"},{"key":"10.1016\/j.htct.2025.103759_bib0004","article-title":"Disease burden, risk factors, and trends of leukaemia: a global analysis","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.htct.2025.103759_bib0005","unstructured":"National Cancer Institute. Acute Myeloid Leukemia. Available from: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/acute-myeloid-leukemia. Accessed 2011."},{"year":"2019","series-title":"Cancer, Acute Myeloid Leukemia (AML, Erythroid Leukemia, Myelodysplasia-Related Leukemia, BCR-ABL Chronic Leukemia)","author":"Vakiti","key":"10.1016\/j.htct.2025.103759_bib0006"},{"key":"10.1016\/j.htct.2025.103759_bib0007","unstructured":"Cancer.Net. Leukemia - acute myeloid - AML - statistics [Internet]. 2012 [cited April 16, 2024]. Available from:https:\/\/www.cancer.net\/cancer-types\/leukemia-acute-myeloid-aml\/statistics#:\u223c:text=The%205%2Dyear%20relative%20survival%20rate%20for%20people%2020%20and."},{"issue":"4","key":"10.1016\/j.htct.2025.103759_bib0008","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41375-021-01425-9","article-title":"Long-term survival after intensive chemotherapy or hypomethylating agents in AML patients aged 70 years and older: a large patient data set study from European registries","volume":"36","author":"R\u00e9cher","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.htct.2025.103759_bib0009","first-page":"23","article-title":"New acute myeloid leukemia therapy","volume":"321","author":"Voelker","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.htct.2025.103759_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/hematology.2020000089","article-title":"Management of toxicities associated with targeted therapies for acute myeloid leukemia: when to push through and when to stop","volume":"2020","author":"Wang","year":"2020","journal-title":"Hematology"},{"key":"10.1016\/j.htct.2025.103759_bib0011","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1200\/EDBK_159061","article-title":"Pharmacogenomics, pharmacokinetics, and pharmacodynamics in the era of targeted therapies","volume":"35","author":"Calvo","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6","key":"10.1016\/j.htct.2025.103759_bib0012","first-page":"730","article-title":"Precision oncology: directing genomics and pharmacogenomics toward reducing cancer inequities","volume":"39","author":"Saulsberry","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2025.103759_bib0013","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.htct.2025.103759_bib0014","first-page":"1","article-title":"Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy","volume":"8","author":"Preissner","year":"2013","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.htct.2025.103759_bib0015","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1074\/jbc.TM118.004144","article-title":"Cytochrome P450 research and the journal of biological chemistry","volume":"294","author":"Guengerich","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.htct.2025.103759_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/bs.apha.2018.04.007","article-title":"Cytochrome P450 in pharmacogenetics: an update","volume":"83","author":"Tornio","year":"2018","journal-title":"Adv Pharmacol"},{"issue":"10197","key":"10.1016\/j.htct.2025.103759_bib0017","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0140-6736(19)31276-0","volume":"394","author":"Roden","year":"2019","journal-title":"Pharmacogenomics Lancet."},{"issue":"1","key":"10.1016\/j.htct.2025.103759_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169233","article-title":"Analysis of genetic variation in CYP450 genes for clinical implementation","volume":"12","author":"Goh","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.htct.2025.103759_bib0019","first-page":"264","article-title":"Glutathione S-transferase GSTM1 and GSTT1 polymorphisms in adult acute myeloid leukemia; its impact on toxicity and response to chemotherapy","volume":"18","author":"Mossallam","year":"2006","journal-title":"J Egypt Natl Canc Inst"},{"issue":"2","key":"10.1016\/j.htct.2025.103759_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.leu.2402361","article-title":"Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy","volume":"16","author":"Naoe","year":"2002","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.htct.2025.103759_bib0021","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00277-014-2050-z","article-title":"GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis","volume":"93","author":"Xiao","year":"2014","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.htct.2025.103759_bib0022","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1479-7364-1-6-460","article-title":"Analysis of the glutathione S-transferase (GST) gene family","volume":"1","author":"Nebert","year":"2004","journal-title":"Hum Genomics"},{"issue":"10","key":"10.1016\/j.htct.2025.103759_bib0023","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1182\/blood-2012-04-424440","article-title":"How I treat hematologic emergencies in adults with acute leukemia","volume":"120","author":"Zuckerman","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.103759_bib0024","unstructured":"Emergencies in leukemia. Kargercom [Internet]. 2019 [cited 2023 Oct 9]. Available from: https:\/\/karger.com\/books\/book\/359\/chapter-abstract\/5561948\/Emergencies-in-leukemia?redirectedFrom=PDF."},{"issue":"1","key":"10.1016\/j.htct.2025.103759_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/hematology.2020000089","article-title":"Management of toxicities associated with targeted therapies for acute myeloid leukemia: when to push through and when to stop","volume":"2020","author":"Wang","year":"2020","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/j.htct.2025.103759_bib0026","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/cancers13050966","article-title":"Response and toxicity to cytarabine therapy in leukemia and lymphoma: from dose puzzle to pharmacogenomic biomarkers","volume":"13","author":"Di Francia","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.htct.2025.103759_bib0027","unstructured":"Acute myeloid leukemia: clinical-epidemiological profile in Brazil between 2009 and 2019 [Internet]. htct.com.br; 2019. Available from: https:\/\/www.htct.com.br\/pt-pdf-S253113792."},{"issue":"1","key":"10.1016\/j.htct.2025.103759_bib0029","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gene.2012.09.113","article-title":"Genetic variability of glutathione S-transferase enzymes in human populations: functional inter-ethnic differences in detoxification systems","volume":"512","author":"Polimanti","year":"2013","journal-title":"Gene"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T15:09:19Z","timestamp":1749654559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2531137925000276"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.103759","relation":{},"ISSN":["2531-1379"],"issn-type":[{"type":"print","value":"2531-1379"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the genetic profile of cytochrome P450 and glutathione S-transferases of patients diagnosed with acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.103759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}],"article-number":"103759"}}